Intermittent Catheters Market Size, Share and Trends Report 2025-2033

Global Intermittent Catheters Market Statistics: USD 4.9 Billion Value by 2033

Summary:

• The global intermittent catheters market size reached USD 2.9 Billion in 2024.
• The market is expected to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.
• North America leads the market, accounting for the largest intermittent catheters market share.
• Urinary incontinence holds the biggest market share on account of the increasing awareness among individuals about urine incontinence.
• Female length catheter accounts for the largest market share due to the rising need to lower the risk of injury or pain.
• The increasing prevalence of urinary disorders, such as urinary incontinence, neurogenic bladder, and benign prostatic hyperplasia (BPH), among the masses around the world is catalyzing the demand for intermittent catheters.
• Innovations in catheter technology are leading to the creation of hydrophilic-coated and antimicrobial catheters that offer enhanced patient comfort and lower infection rates.

Industry Trends and Drivers:

• Growing Prevalence of Urinary Disorders:

The rising prevalence of urological disorders such as urinary incontinence, neurogenic bladder and benign prostatic hyperplasia (BPH) among people across the globe is driving the demand for intermittent catheters. Since these conditions often disrupt the normal functioning of the bladder, patients require regular catheters to manage their urine output. An increasing number of individuals, especially the elderly and those with spinal cord injuries or neurological conditions, are facing these disorders, which is fueling the market growth. Additionally, lifestyle factors including poor dietary habits, obesity and sedentary lifestyle are expanding the market for intermittent catheters as an essential tool for effective management.

• Technological Advancements and Product Innovations:

Innovations in catheter technology have led to the creation of hydrophilic-coated and antimicrobial catheters, which provide improved patient comfort and lower infection rates. These advancements address the main concerns of the user, such as discomfort during insertion and the risk of urinary tract infections (UTIs). In addition, advancements such as pre-lubricated and single-use disposable catheters are making self-catheterization more accessible and convenient for patients. As technology continues to evolve, new products are emerging that improve safety and ease of use, increasing their use among patients and healthcare providers.

• Increasing Awareness and Adoption in Home Care:

Increasing awareness among individuals about the benefits of intermittent catheterization compared to other forms, such as indwelling catheters, is supporting the market growth. Healthcare professionals and organizations are increasingly promoting intermittent catheters due to lower risk of infection and greater convenience for patients. In addition, high healthcare costs as well as increasing preferences for home care solutions are contributing to the market growth. The shift toward home-based care and self-management, especially among the older population, is fueling the market growth. Patients want comfortable and effective urinary management solutions that can be used independently.

Request for a sample copy of this report: https://www.imarcgroup.com/intermittent-catheters-market/requestsample

Intermittent Catheters Market Report Segmentation:

By Product:

• Uncoated Intermittent Catheter
• Coated Intermittent Catheter

  • Antimicrobial
  • Hydrophilic
  • Others

Uncoated intermittent represents the largest segment as it enhances patient comfort and infection control.

By Indication:

• Urinary Incontinence
• Surgery (Major Surgery)
• Spinal Cord Injury
• Others

Urinary incontinence holds the biggest market share on account of the increasing awareness among individuals about urine incontinence.

By Category:

• Male Length Catheter
• Kids Length Catheter
• Female Length Catheter

Female length catheter accounts for the largest market share due to the rising need to lower the risk of injury or pain.

By End User:

• Hospitals
• Medical Research Centers
• Ambulatory Surgical Centers

Hospitals exhibit a clear dominance in the market, driven by their ability to handle a higher volume of patients.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the intermittent catheters market, which can be attributed to the high prevalence of urological disorders.

Top Intermittent Catheters Leaders: 

The intermittent catheters market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• B. Braun Melsungen AG
• Becton Dickinson and Company
• Coloplast A/S
• Cure Medical LLC (Convatec Group plc)
• Hollister Incorporated
• Hunter Urology
• Medical Technologies of Georgia Inc.
• Pennine Healthcare Ltd.
• Teleflex Inc
• Wellspect Limited (Dentsply Sirona).

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145